|
Real-time Estimate
Cboe BZX
21:53:49 13/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.640 USD | -0.72% |
|
+2.23% | -8.29% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 06-01 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.72% | +2.23% | +4.33% | -10.75% | -8.29% | +57.87% | -20.77% | -19.75% | - | 1.33B | |
| +2.07% | +10.05% | +31.65% | +47.13% | +79.09% | +77.41% | +106.53% | +16.62% | - | 70.1B | |
| -0.87% | +0.08% | -0.68% | +9.78% | +5.25% | +36.96% | +65.04% | +182.97% | +5,378.58% | 54.93B | |
| -3.16% | -3.70% | +16.96% | +8.19% | -26.65% | +3.89% | +472.42% | +441.81% | +917.94% | 28.89B | |
| +0.04% | +12.56% | +20.44% | +35.67% | +45.42% | +54.67% | +5.47% | -61.93% | - | 23.9B | |
| -0.09% | +1.32% | +2.58% | +0.17% | -2.95% | -18.08% | -14.01% | -75.51% | - | 23.3B | |
| +0.35% | +8.24% | +12.45% | +125.44% | +241.04% | +252.94% | +466.50% | +1,800.42% | +864.12% | 18.41B | |
| -0.59% | +7.88% | +6.38% | +20.25% | -0.10% | +40.87% | -20.12% | -31.36% | +78.73% | 18.77B | |
| -0.57% | +6.85% | +1.74% | +14.04% | +33.99% | +30.20% | +580.70% | - | - | 16.1B | |
| +1.18% | -2.52% | -9.20% | -0.79% | +16.10% | +32.20% | +136.56% | +178.36% | +372.91% | 12.48B | |
| -0.72% | +0.67% | +16.59% | +10.95% | +30.15% | +332.24% | +193.99% | +42.77% | +1,311.85% | 12.32B | |
| -4.69% | +0.51% | -3.40% | -1.14% | -11.91% | +37.35% | +195.76% | +504.48% | +6,205.59% | 12.39B | |
| -2.62% | +8.16% | -4.28% | -22.06% | -16.27% | -45.50% | +639.65% | +84.91% | +116.96% | 12.05B | |
| +1.47% | +8.48% | +6.53% | -20.31% | -8.32% | -33.80% | +208.79% | +135.99% | - | 11.98B | |
| -1.73% | -8.79% | -9.75% | -3.89% | +16.81% | +101.25% | +131.21% | +130.86% | +510.86% | 10.52B | |
| +0.24% | -0.06% | -1.90% | -13.07% | +14.58% | +25.19% | +119.41% | -26.34% | - | 8.99B | |
| -1.97% | -1.39% | +8.80% | +33.64% | +211.29% | +486.09% | +766.07% | -32.35% | -13.02% | 9.18B | |
| -0.02% | +0.65% | +0.95% | +125.36% | +81.45% | +180.71% | +401.57% | +279.45% | - | 8.96B | |
| -0.51% | +0.71% | +4.00% | +9.33% | +28.54% | +87.99% | +28.93% | +127.85% | - | 8.88B | |
| -0.84% | +4.24% | -2.05% | -6.38% | +285.36% | +170.57% | +312.44% | -32.18% | - | 8.2B | |
| Average | -0.68% | +5.28% | +5.11% | +18.08% | +50.73% | +95.55% | +238.81% | +191.95% | +1,574.45% | 18.58B | |
| Weighted average by Cap. | -0.33% | +6.71% | +9.86% | +23.52% | +45.07% | +75.33% | +200.86% | +194.45% | +2,336.14% |
- Stock Market
- Stocks
- IMTX Stock
- Sector Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
